Metabolic Syndrome and Cardiovascular Disease: A Health Challenge in Mexico
Metabolic Syndrome (MetS) is a cluster of risk factors that, taken alone or synergically, are independent predictors of type 2 diabetes and cardiovascular disease (CVD), which are both major public health problems that requires urgent containment actions. Current controversies regarding MetS are focused on ascertain the unifying explanation of molecular and pathophysiological mechanisms originating the syndrome, involving insulin resistance and low-grade chronic inflammation. This review aims to present the clinical relevance of MetS and its complications, as well as the hypotheses addressing its etiopathogenic relation with CVD.
Source: Archives of Medical Research - Category: Research Authors: Antonio Gonzalez-Ch ávez, José Alejandro Chávez-Fernández, Sandra Elizondo-Argueta, Alonso González-Tapia, José Israel León-Pedroza, Cesar Ochoa Tags: Review Article Source Type: research
More News: Cardiology | Cardiovascular | Diabetes | Diabetes Type 2 | Endocrinology | Heart | Insulin | International Medicine & Public Health | Israel Health | Metabolic Syndrome | Mexico Health | Middle East Health | Research